focus -WSS

focus

author：comprehensive 2025-09-04 22:02:04 - browse：51

Amylyx founders — Justin Klee (left) and Joshua Cohen are the co-founders and co-CEOs of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

Amylyx Pharmaceuticals said Friday that its treatment for ALS, called Relyvrio, failed to provide any benefit for patients in a large clinical trial — a stunning outcome that now has the company considering a voluntary withdrawal of the approved medicine from the market.

“This is really hard for us, and it’s really hard for our team who care so much, but it’s so much harder for people with ALS and their families, and we have to keep that perspective,” said a somber Justin Klee, Amylyx’s co-founder and co-CEO, in an interview with STAT on Thursday evening.

In the Phase 3 study involving 664 people with ALS, Relyvrio failed to outperform a placebo on an ALS functional rating scale that measures the ability to perform daily living tasks, walk, breathe, speak, and swallow. The company did not provide detailed results for the study’s primary goal, but said the calculation for statistical significance was 0.67 — well above the 0.05 threshold for success and an indication that Relyvrio provided no benefit at all.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Readout Newsletter: Bluebird, CVS, Contineum

WSS

5 to watch: Tech startups trying to solve health care's staffing crisis

Future doctors should be trained to promote social change

Vermont grapples with historic flooding as more rainstorms head for Northeast

Creating egg and sperm cells from stem cells raises ethical issues

Asbestos, a deadly carcinogen, banned by EPA

Readout Newsletter: Bluebird, CVS, Contineum

Wikipedia

focus

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

5 to watch: Tech startups trying to solve health care's staffing crisis

Jerome Adams on the need for new antivirals for Covid

Intermittent fasting comes with a heart risk? Not so fast

Medicare details structure of new drug price negotiation program

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Jerome Adams on the need for new antivirals for Covid

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

focus

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Watch the official trailer for 'Ahsoka' series

Superbugs, antibiotic resistance get scrutiny in congress

Nurses recount patients attacks

Future doctors should be trained to promote social change

Future doctors should be trained to promote social change

hotspot

focus

hotspot

focus